Results 151 to 160 of about 62,852 (172)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Human Vaccines and Immunotherapeutics, 2019
Helen L Stacey, Luwy Musey
exaly  

Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age

Vaccine, 2014
Richard N Greenberg, Robert W Frenck, James Trammel   +2 more
exaly  

Pneumococcal vaccine development

Expert Review of Vaccines, 2004
Jan T Poolman
exaly  

Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine

Expert Review of Vaccines, 2009
Ener Çagri Dinleyici
exaly  

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

Lancet, The, 2005
O S Levine, S K Obaro, Keith P W J McAdam   +2 more
exaly  

Pneumococcal polysaccharide vaccines

The Indian Journal of Pediatrics, 1982
openaire   +2 more sources

Pneumococcal vaccine and the elderly

The Lancet, 2000
openaire   +2 more sources

Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older

Vaccine, 2013
Robert W Frenck, John Treanor, Kathrin U Jansen   +2 more
exaly  

Effectiveness of pneumococcal vaccine

The Lancet, 1998
M C, Steinhoff, L, Moulton, J, Clemens
openaire   +2 more sources

Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia

Clinical Microbiology and Infection, 2013
Joaquin Burgos, Jordi Rello
exaly